Ophthalmology is becoming a stronger specialty-care focus for Lupin as the company expands its European eye-care business through VISUfarma
Glenmark’s latest USFDA approval covers Fluticasone Propionate Nasal Spray. The FDA has determined the product to be bioequivalent and therapeutically equivalent to Flonase Nasal Spray
India’s heart-lung machine market is set for a major shift as a homegrown device gains key regulatory approvals. The heart-lung machine developed by Mediyant Technologies has received USFDA 510(k) clearance and CDSCO approval.
Indian skincare is entering a new growth phase as established consumer companies move deeper into premium and science-backed beauty
Hearzap today announced the successful completion of its acquisition of Amplifon India's hearing healthcare business. The acquisition took place after definitive agreement announced in May 2026, marking one of the most significant developments...
The GLP-1 boom is pushing companies across consumer industries to rethink what people eat, drink, and buy. Weight-loss drugs are creating new demand beyond the pharmaceutical sector. Companies now see opportunities in nutrition, food, beverages...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Gland Pharma reported a strong Q1 profit. The company posted revenue of INR 1,800.27 crore in Q1 FY27. Its net profit rose 47.1% year over year to INR 316.95 crore.
India’s MedTech industry is entering a new phase of growth as domestic manufacturing, technology innovation, global partnerships, and healthcare demand reshape the medical devices sector.
.jpg)
, CDSCO.jpg)
